JP2019041581A - Chemical volatilizing container and chemical volatilizing device - Google Patents

Abstract

Disclosed are a chemical volatilization container and a chemical volatilization device that are excellent in retention and volatility of a volatile chemical, are small in size and light in weight, and are difficult to touch when the chemical is filled. A chemical volatilization container 20 accommodates a chemical volatilization body 10 that holds a volatilizing chemical, a main body part that accommodates the chemical volatilization body 10, and a lid part that has a drug filling port in a substantially central part. And has a raised drug filling portion at a substantially central portion of the main body portion. By having the raised drug filling portion, the drug volatilizer can be efficiently impregnated with a large amount of the volatile drug, and the volatile drug can be efficiently volatilized. [Selection] Figure 1

Description

  The present invention relates to a drug volatilization container and a drug volatilization apparatus, and particularly to a drug volatilization container and a drug volatilization apparatus for holding a volatile drug.

  Various types of containers for storing volatile drugs such as pest repellents have been proposed. For example, Patent Document 1 discloses that an adhesive layer is provided on one surface of an insect repellent body in which a repellent or a low-toxic insecticide that volatilizes at room temperature or body temperature is impregnated with a carrier such as paper, a plastic sheet, or a continuous foamed plastic foam. The provided insect repellent is disclosed.

  However, although the insect repellent of Patent Document 1 is small, light and highly convenient, there is a problem that the retention and volatility of the drug is not always sufficient and the pest control effect cannot be sufficiently exhibited.

JP-A-9-154470 JP 2005-31335 A JP 2007-116967 A JP 2010-29173 A

  In order to solve the problem that sufficient volatility cannot be obtained, in Patent Document 2, a blower is rotated by a battery-driven motor, and air is sucked into and discharged from a drug container containing the volatilizable drug. An air blowing type drug diffusing device is disclosed which actively dissipates.

  However, although the blowing type chemical | drug | medicine diffusion apparatus of patent document 2 can dissipate a volatile chemical | medical agent actively and can exhibit a pest control effect efficiently, a motor and a battery are needed as a drive means of an air blower. Therefore, in Patent Document 2, in order to reduce the size and weight of the apparatus main body, a power source main body including a power source that is a heavy object is provided separately from the apparatus main body, the apparatus main body is attached to a wrist or the like, Store the main body in your trousers or clothes pocket. At that time, the apparatus main body and the power supply main body are connected by a connecting cord, and the distance between the apparatus main body and the power supply main body is restricted by the connecting cord, which hinders the user's operation.

  In order to solve the problem of the weight of the power supply body after the apparatus main body and the power supply body are integrated, in Patent Document 3, the drug is prepared by containing the drug in a breathable carrier formed by folding the bellows. There is disclosed a chemical volatilization apparatus in which an impregnated body is accommodated in a disk-shaped cartridge not equipped with a fan and includes a solar cell and a charger.

  However, since Patent Document 3 also requires a motor drive unit and a power supply unit, a space for housing these inside the apparatus main body is required, and in order to use the drug volatilization apparatus for portable use, a further small size is required. There was room for reduction in weight and weight.

  In order to solve the problem of efficiently volatilizing the volatile drug without using the driving means of the drug volatilization apparatus, Patent Document 4 discloses that the volatile drug is applied to the net-shaped drug volatilization body without using the driving means such as a blower. A chemical volatilization apparatus for impregnating with water is disclosed. In the drug volatilization apparatus of Patent Document 4, the container is provided with at least one volatile drug supply means having a flat plate part and a dish-shaped part, and the drug holding body is a surface part of the flat plate part and the dish-shaped part. A plurality of through holes are provided in the bottom portion of the dish-shaped portion.

  However, in Patent Document 4, the drug holder can be efficiently impregnated and diffused with a large amount of the volatile drug, and the supply efficiency of the volatile drug during production can be increased, but the drug is held in the volatile drug supply unit. Since the body is arranged, there is a problem that the medicine is easy to touch.

  Therefore, the present invention solves the above problems, achieves excellent drug retention and volatility, realizes further miniaturization and weight reduction, and in addition, a drug volatilization container that is difficult for the drug to touch when filling the drug and A chemical volatilization device is provided.

  In order to solve the above-mentioned problems, in the present invention, by providing a raised drug filling part in the main part of the drug volatilization container containing the drug volatilization body, the drug volatilization body is efficiently impregnated with a large amount of the volatility drug, The present invention provides a chemical volatilization container and a chemical volatilization device that can volatilize a volatile chemical efficiently, achieve a reduction in size and weight, and can be safely used because the chemical is difficult to touch.

  Further, in the drug volatilization container and the drug volatilization apparatus according to the present invention, the volatilization drug is stored in the drug volatilization body by winding the belt-shaped drug volatilization body holding the volatile drug in a spiral shape and storing it in the drug volatilization container. It is possible to efficiently impregnate a large amount, volatilize a volatile drug efficiently, to realize a reduction in size and weight, and to further enhance the above-described effect that the drug is difficult to touch and can be used safely.

  In the first aspect of the present invention, a drug volatilization container that stores a drug volatilizer that holds a volatile drug, a main body that stores the drug volatilization body, and a lid that has a drug filling port at a substantially central portion. The drug volatilization container having a raised drug filling part at a substantially central part of the main body part is provided.

  A volatile chemical | medical agent is thrown in toward the chemical | medical agent filling part provided in the main-body part from the chemical | medical agent filling port provided in the cover part. Since the drug filling portion is raised, the volatile drug can easily flow to the drug volatile body, and the volatile drug can be efficiently impregnated in a large amount. Moreover, since the space in the drug volatilization container can be effectively utilized by the raised drug filling part, it is possible to contribute to downsizing and weight reduction of the entire drug volatilization container.

  In a state where the lid portion is fitted to the main body portion, the upper end of the medicine filling port and the medicine filling portion are separated by the thickness of the lid portion. Therefore, when the hand touches the upper part of the lid part, the drug filling part is not touched directly, so that the volatile drug can be made difficult to touch when filling the volatile drug.

  Moreover, since the chemical | medical agent filling part has protruded, a volatile chemical | medical agent flows easily to a chemical | medical agent volatilization body, and the state by which the volatile chemical | medical agent was impregnated at the chemical | medical agent volatilization body can be implement | achieved rapidly. In addition, it is difficult for the volatile drug to stay in the drug filling part, and it is difficult for the drug filling part to remain moistened by the volatile drug. In addition, although the drug filling part is separated by the lid part, it directly touches the outside air. The filled volatile drug is efficiently volatilized from the drug filling part. This can also prevent the volatile drug from touching the hand.

  According to a first aspect of the present invention, there is provided a drug volatilization device comprising a drug volatilizer that holds a volatile drug and a drug volatilization container that accommodates the drug volatilizer, and the drug volatilizer has a strip shape. And wound in a spiral shape and accommodated in the drug volatilization container, the drug volatilization container includes a main body part that accommodates the drug volatilization body, and a lid part that has a drug filling port in a substantially central part, The drug volatilization device having a raised drug filling part at a substantially central part of the main body part is provided.

  The chemical volatilization apparatus is configured by arranging a chemical volatilization body holding a volatile chemical in a chemical volatilization container having the above-described raised drug filling part. The chemical volatilization body has a long band shape before being placed in the chemical volatilization container, but when placed in the chemical volatilization container of the present invention, it is held in a spiral shape. The In this invention, it discovered that the chemical | medical agent volatilization body wound by the spiral form made a clearance gap mutually for every round, and was suitable for volatilizing a volatile chemical | medical agent efficiently. That is, the drug volatilization container according to the present invention has a structure suitable for holding the drug volatilized body wound in a spiral shape so that an effective gap is generated every round.

  In the medicine volatilization container according to the first aspect of the present invention, the medicine filling portion preferably protrudes in a substantially conical shape in a substantially vertical direction. This enhances the effect of preventing the filled volatile drug from efficiently flowing into the drug volatile body and preventing the volatile drug from stagnation in the drug filling part, and effectively impregnating the volatile drug into the drug volatile body. it can. Moreover, it can also prevent that a volatile chemical | medical agent touches a hand.

  Moreover, the chemical | medical agent volatilization container in the 1st aspect of this invention WHEREIN: The said main-body part has an accommodating part which accommodates the said chemical | medical agent volatilization body, and this accommodating part is arrange | positioned so that the said chemical | medical agent filling part may be surrounded. Since the drug volatilizer is accommodated in the container so as to surround the drug filling part, when the volatile drug flows from the raised drug filling part toward the drug volatilizer, the volatile drug flows in any direction. Also, the volatile drug can be reliably captured, and the volatile drug can be prevented from leaking during filling.

  Further, in the drug volatilization container according to the first aspect of the present invention, the main body portion has a plurality of boundary walls at the boundary between the drug filling portion and the storage portion, and each of the plurality of boundary walls is mutually connected. Arranged at intervals. Since the plurality of boundary walls separating the drug filling part and the storage part are arranged with a space between each other, the volatile drug reaches the drug volatilizer from between the boundary walls.

  According to a first aspect of the present invention, there is provided a drug volatilizer that retains a volatilizable drug, which has a strip shape and is wound in a spiral shape. As described above, the chemical volatilization body according to the present invention has a long strip shape before being placed in the chemical volatilization container, and when it is placed in the chemical volatilization container, it is wound in a spiral shape. Held in. By using a chemical volatilization body wound in a spiral shape, a gap is formed between each round, so that it is possible to efficiently volatilize the volatile chemical. Further, by winding the long drug volatilization body in a spiral shape, the storage space can be reduced, and the size of the drug volatilization container and the entire drug volatilization apparatus can be reduced.

  The chemical volatilization body in the first aspect of the present invention preferably has a plurality of openings. Volatilization can be further improved by providing a plurality of openings in the chemical volatilization body. Preferably, a plurality of openings may be provided by allowing the chemical volatilizer to form a network. When the drug volatilization body is wound in a spiral shape, the plurality of openings are typically staggered, and the volatility of the volatile drug can be further enhanced by a synergistic effect with the gap generated every round.

  The chemical volatilization body in the first aspect of the present invention forms a plurality of layers by being spirally wound, and has a gap between each of the plurality of layers. As described above, since the chemical volatilization body is wound in a spiral shape, a plurality of layers are formed, and gaps are formed between the plurality of layers, whereby the volatilizing chemical can be efficiently volatilized.

  According to the present invention, by providing a protruding drug filling part in the main body part of the drug volatilization container that contains the drug volatilization body, the drug volatilization body is efficiently impregnated with a large amount of the volatilization drug, and the volatilization drug is efficiently used. Can be volatilized well. Moreover, the chemical volatilization container can be reduced in size and weight by the structure of the chemical volatilization container including the raised drug filling part. Therefore, it can be suitably used for portable use. Furthermore, it is possible to safely use the drug in the filling part of the volatile drug because it is difficult to touch the hand.

In addition, by swirling a strip-shaped drug volatilizer that holds the volatile drug in a spiral shape and storing it in the drug volatilization container, the drug volatilizer is efficiently impregnated with a large amount of the volatile drug, and the volatile drug is efficiently absorbed. It is possible to further enhance the above-described effect of volatilizing well and reducing the chemical volatilization container in size and weight.
Other objects, features and advantages of the present invention will become apparent from the following description of embodiments of the present invention with reference to the accompanying drawings.

FIG. 1 is a perspective view showing a drug volatilization apparatus according to a first embodiment of the present invention. FIG. 2 is a perspective view showing a drug volatilization container according to the first embodiment of the present invention. FIG. 3 is a perspective view showing a state in which the drug volatilization body is housed in the main body part of the drug volatilization container according to the first embodiment of the present invention. FIG. 4A is a diagram showing an example of a chemical volatilization body according to the first example of the present invention. FIG. 4B is a view showing a preferred example of the chemical volatilization body according to the first embodiment of the present invention. FIG. 5A is a plan view of the chemical volatilization device according to the first embodiment of the present invention. 5B is a cross-sectional view taken along line VB-VB of the chemical volatilization apparatus in FIG. 5A. FIG. 6 is a diagram showing the results of a volatilization test of a chemical volatilization body.

  FIG. 1 is a perspective view showing a drug volatilization apparatus 1 according to a first embodiment of the present invention. The chemical volatilization apparatus 1 includes a chemical volatilization body 10 that holds a volatile chemical and a chemical volatilization container 20 that accommodates the chemical volatilization body 10. The drug volatilization body 10 has a strip shape, is wound in a spiral shape, and is accommodated in the drug volatilization container 20. The chemical volatilization body 10 accommodated in the chemical volatilization container 20 is exposed to the outside air through a plurality of vents 33 provided in the chemical volatilization container 20, and the volatile chemicals held in the chemical volatilization body 10 are a plurality of permeable chemicals. Volatilizes through the pores 33.

  The chemical volatilization apparatus 1 is configured by arranging a chemical volatilization body 10 that holds a volatile chemical in a chemical volatilization container 20. The chemical volatilization body 10 forms a long band before being placed in the chemical volatilization container 20, but when placed in the chemical volatilization container 20, it is held in a spirally wound state. The By winding the drug volatilization body 10 in a spiral shape, a gap is formed between each round, and it is possible to volatilize the volatile drug efficiently. The chemical volatilization container 20 holds the chemical volatilization body wound in a spiral shape so that an effective gap is generated every round.

  The outer shape of the drug volatilization apparatus 1 is preferably substantially cylindrical, preferably about 40 to 50 mm in diameter and about 15 to 25 mm in height, but is not limited to this and should be small enough to be portable. That's fine.

  FIG. 2 is a perspective view showing the drug volatilization container 20 according to the first embodiment of the present invention. The drug volatilization container 20 includes a main body part 21 that accommodates the drug volatilization body 10 and a lid part 22 having a drug filling port 31 in a substantially central part. Further, the drug volatilization container 20 has a raised drug filling part 30 at a substantially central part of the main body part 21. The volatile drug is introduced into the drug filling part 30 provided in the main body part 21 through the drug filling port 31 provided in the lid part 22. Since the drug filling part 30 is raised and forms a slope from the center to the outside, the volatile drug easily flows to the drug volatilizer 10, and the drug volatilizer 10 is efficiently impregnated with a large amount of the volatile drug. can do. Further, since the space in the drug volatilization container 20 can be effectively utilized by the raised drug filling part 30, it is possible to contribute to the reduction in size and weight of the entire drug volatilization container 20.

  In a state where the lid portion 22 is fitted to the main body portion 21, the upper end of the medicine filling port 31 and the medicine filling portion 30 are separated by the thickness of the lid portion 22. Therefore, when a hand touches the upper part of the cover part 22, it does not touch the chemical | medical agent filling part 30 directly, but when a volatile chemical | medical agent is filled, it can make it difficult to touch a volatile chemical | medical agent. Moreover, since the chemical | medical agent filling part 30 protrudes, a volatile chemical | medical agent flows easily to the chemical | medical agent volatilization body 10, and the state where the volatile chemical | medical agent was impregnated at the chemical volatilization body 10 can be implement | achieved rapidly. In addition to the fact that the volatile drug is unlikely to stagnate in the drug filling unit 30 and the drug filling unit 30 is less likely to remain moistened by the volatile drug, the drug filling unit 30 is separated from the outside air by the lid 22. Since the volatile chemical | medical agent with which it filled directly is touched, it volatilizes from the chemical | medical agent filling part 30 efficiently. This can also prevent the volatile drug from touching the hand.

  The main body 21 includes an accommodating portion 34 that accommodates the drug volatilizer 10, a drug filling portion 30 that is filled with a drug, a plurality of boundary walls 32 that are disposed at the boundary between the drug filling portion 30 and the accommodating portion 34, Side wall 35. The main body portion 21 is suitable for holding the drug volatilization body 10 wound in a spiral shape so that an effective gap is generated every round due to the structure of each part described later. The main body 21 may further have a plurality of vent holes 36. By providing a plurality of ventilation holes 36 in the main body 21, the chemical volatilization body 10 accommodated in the accommodation part 34 can easily touch the outside air, and the volatility of the volatile chemical can be further increased.

  The lid portion 22 has a drug filling port 31 at a substantially central portion. The drug filling part 30 provided in the substantially central part of the main body part 21 is exposed through the drug filling port 31 of the lid part 22. That is, the position of the medicine filling port 31 corresponds to the position of the medicine filling part 30 of the main body 21, and the medicine filling part 30 is arranged to be exposed through the medicine filling port 31. Since the drug filling part 30 touches the outside air through the drug filling port 31 of the lid part 22, after the volatile drug is impregnated in the drug volatilizer 10, the drug remaining in the drug filling part 30 is quickly dried and It is possible to avoid adhesion of the drug to the etc. Further, since the medicine filling unit 30 is separated from the upper end of the medicine filling port 31 by the thickness of the lid part 22, even when the hand touches the upper part of the lid part 22, Do not touch directly. Therefore, when filling the volatile drug, the volatile drug can be made difficult to touch.

  The lid portion 22 is provided with a plurality of vent holes 33. The volatile chemical impregnated in the chemical volatilization body 10 is volatilized through the plurality of vent holes 33 of the lid portion 22. By providing a plurality of vent holes 33 in the lid portion 22, the chemical volatilization body 10 can touch the outside air through the vent holes 33 and efficiently volatilizes the volatile chemical impregnated in the chemical volatilization body 10. be able to. In addition, the number and arrangement | positioning of the some ventilation hole 33 shown in FIG. 2 are examples, and are not restricted to this.

  The medicine filling port 31 provided in the lid part 22 is preferably circular, but is not limited thereto, and the medicine filling part 30 provided in the substantially central part of the main body part 21 is exposed through the medicine filling port 31. If possible, it may be an arbitrary shape such as a polygon such as a triangle or a quadrangle. The diameter of the medicine filling port 31 is preferably about 18 mm. However, the diameter is not limited to this. If the volatile medicine can be introduced from the medicine filling port 31, it may have an arbitrary diameter such as 5 to 30 mm. Good. The depth of the medicine filling port 31 is preferably substantially the same as the height of the lid portion 22, that is, the thickness of the lid portion 22 in the vertical direction, but the main body portion 21 and the lid portion 22 are fitted together. In doing so, it is preferable that the bottom of the medicine filling port 31 does not directly contact the medicine filling portion 30. The depth of the medicine filling port 31 is preferably about 11 mm, but is not limited thereto, and may have an arbitrary depth such as about 5 mm to 15 mm.

  The body portion 21 and the lid portion 22 are preferably fitted by pressing the lid portion 22 in a substantially vertical direction, but may be fitted to the body portion 21 while rotating the lid portion 22. In a state where the main body 21 and the lid 22 are fitted, the drug filling portion 30 of the main body 21 is exposed through the drug filling port 31 of the lid 22. As above-mentioned, since the chemical | medical agent filling part 30 touches external air directly, the filled volatile chemical | medical agent is easy to dry quickly, and the state where the volatile chemical | medical agent was impregnated by the chemical | medical agent volatilization body 10 can be implement | achieved rapidly. Further, by fitting the main body portion 21 and the lid portion 22, the upper end of the medicine filling port 31 and the medicine filling portion 30 are separated by the thickness of the lid portion 22, and the hand is located above the lid portion 22. Since the drug filling unit 30 is not directly touched when touched, the volatile drug can be made difficult to touch when filling the volatile drug.

  The volatile drug is a liquid, and preferably contains a component having an effect of pest repellent or pest control. For example, you may make it contain the component which has the effect of pest repellent or pest control, such as organic phosphorus type | system | group, a carbamate type | system | group, and a pyrethroid type | system | group. For example, DDVP, diazinon, sumithion, or the like may be used as an organophosphorus pest repellent or pest control agent. Further, as a carbamate pest repellent or a pest control agent, propoxer, carbaryl and the like may be used. In addition, as a pyrethroid-based pest repellent or pest control agent, areleslin, phthalthrin, resmethrin, flamethrin, permethrin, phenothrin, fenvalerate, esfenvalerate, praletrin, tefluthrin, transfluthrin, methfluthrin, profluthrin, cypermethrin, ciphenothrin, Fenpropatoline, fenfluthrin, empentrin, terrareslin, etofenprox, imiprotorin and the like may be used. Further, as other pest repellents or pest control agents, amidoflumet, methoxadiazone, plant essential oil, terpene, and isomers and derivatives thereof may be used.

  Volatile drugs exhibit pest repellent or pest control effects when the active ingredient is volatilized in the air. Volatile drugs are not limited to those containing components that have pest repellent or pest control effects, as long as the active ingredients exhibit their effects by evaporating in the air. It may be. For example, the volatile chemicals may contain components having effects such as aroma, deodorization, sterilization, antifungal and antiviral.

  For example, as a fragrance, scented scented dragon, incense, abies oil, almond oil, pegle oil, perch oil, kayabuchi oil, citronella oil, eucalyptus oil, fennel oil, garlic oil, ginger oil, grapefruit oil, lemon oil, lemon Glass oil, nutmeg oil, mint oil, orange oil, turpentine oil, sage oil, lavender oil and other essential oils, pinene, limonene, linalool, geraniol, citronellal, borneol, pendyl alcohol, anise alcohol, anethole, eugenol, Aldehyde, citral, citronellal, vanillin, carvone, ketone, menthone, menthol, acetophenone, coumarin, cineol, ethyl acetate, octyl acetate, butyl propionate, isopropyl isobutyrate, allyl caproate, Kosan ethyl, methyl cinnamate, may be used any flavors such as methyl salicylate.

  For example, as a deodorant, lauryl methacrylate, geranyl chloride, acetophenone myristate, paramethylacetophenone benzaldehyde, benzyl acetate, benzyl propionate, amylcinnamic aldehyde, anisic aldehyde, diphenyl oxide, methyl benzoate, ethyl benzoate, Methyl phenylacetate, ethyl phenylacetate, neoline, safrole, citronella oil, lemongrass oil and the like may be used.

  For example, hinokitiol, phenoxyethanol, isopropylmethylphenol, thiabendazole, chlorine dioxide or the like may be used as a bactericidal / antifungal agent.

  For example, quaternary ammonium salts such as octadecyltrimethylammonium chloride and hexadecyltrimethylammonium chloride, hinokitiol, chlorine dioxide and the like may be used as antiviral agents.

  In the drug volatilization container 20 of the present invention, the main body 21 has a storage part 34 that stores the drug volatilization body 10, and the storage part 34 is disposed so as to surround the drug filling part 30. Even if the container 34 is arranged so as to surround the drug filling part 30, the volatile drug charged into the drug filling part 30 through the drug filling port 31 flows in any direction. It becomes possible to capture the volatile drug by the drug volatilizer 10 stored in the storage unit 34. Thereby, when filling, it can prevent that a volatile chemical | medical agent leaks.

  As shown in FIG. 2, the accommodating portion 34 is a portion surrounded by the boundary wall 32 and the side wall 35 of the main body portion 21, and forms a hollow cylindrical space. The bottom surface of the accommodating portion 34 has a hollow circular shape, the hollow circular inner circle is defined by the plurality of boundary walls 32, and the hollow circular outer circle is defined by the side wall 35 of the main body portion 21. The The width of the accommodating portion 34, that is, the length obtained by subtracting the radius of the inner circle from the radius of the outer circle is preferably about 7 mm, but is not limited to this, for example, a desired width such as about 5 mm to 15 mm. It is good.

  Further, in the drug volatilization container 20 of the present invention, the main body part 21 has a plurality of boundary walls 32 at the boundary between the drug filling part 30 and the storage part 34, and each of the plurality of boundary walls 32 is spaced from each other. Arranged. Each of the plurality of boundary walls 32 is disposed with a space therebetween, so that the volatile drug reaches between the plurality of boundary walls 32 and reaches the drug volatilizer 10.

  The plurality of boundary walls 32 are preferably arranged in a circular shape at intervals between each other at the boundary between the medicine filling unit 30 and the storage unit 34. The plurality of boundary walls 32 are preferably arranged at equal intervals, but may be arranged at different intervals. The shape of each boundary wall 32 is preferably a substantially rectangular plate shape, and may be slightly curved along the circumference of a circle that forms the boundary between the medicine filling portion 30 and the accommodating portion 34. You may make it form a plane without doing. The width of each boundary wall 32 is preferably about 4 mm, but is not limited thereto, and may be a desired width such as about 2 mm to 10 mm. The number of the plurality of boundary walls 32 is eight in the example of FIG. 2, but is not limited thereto, and may be an arbitrary number.

  In addition, in the drug volatilization container 20 of the present invention, the drug filling unit 30 protrudes in a substantially conical shape in a substantially vertical direction when the drug volatilization container 20 is placed on a horizontal plane. Since the drug filling part 30 has a shape that rises in a substantially conical shape in a substantially vertical direction, the volatile drug charged from the drug filling port 31 flows toward the drug volatilizer 10 and infiltrates the drug volatilizer 10. Therefore, it is possible to prevent the volatile drug from remaining in the drug filling unit 30 and efficiently impregnate the volatile drug in the drug volatile body 10. Further, the volatile drug naturally flows from the upper side to the lower side in the vertical direction along the slope of the drug-filled portion 30 having a substantially conical shape. Therefore, when the volatile drug is infiltrated into the drug volatilization body 10, it is not necessary to tilt the drug volatilization container 20. The possibility of adhering to the body or the like can also be avoided.

  The diameter of the medicine filling portion 30 is preferably about 20 mm, but is not limited thereto, and may have a desired diameter such as about 7 mm to 30 mm.

  FIG. 3 is a perspective view showing a state in which the drug volatilization body 10 is accommodated in the main body 21 of the drug volatilization container 20 according to the first embodiment of the present invention. The chemical volatilization body 10 is accommodated in the accommodating portion 34 of the main body portion 21. The accommodating portion 34 is a portion surrounded by the boundary wall 32 and the side wall 35 of the main body portion 21 and forms a hollow cylindrical space. The chemical volatilization body 10 is formed in a band shape and is wound in a spiral shape to form a hollow cylindrical shape that matches the shape of the accommodating portion 34.

  The chemical volatilization body 10 is formed in a long band before being placed in the chemical volatilization container 20, and when being placed in the chemical volatilization container 20, it is held in a spirally wound state. . By winding the long drug volatilization body 10 in a spiral shape, the storage space can be reduced, and the size of the drug volatilization container 20 and the entire drug volatilization apparatus 1 can be reduced.

  Moreover, the chemical volatilization body 10 is formed in a plurality of layers by being spirally wound, and has a gap between each of the plurality of layers. By having a gap between each of the plurality of layers, the volatile drug is easily volatilized. Both ends of the chemical volatilization body 10 housed in the housing part 34 are not locked, but are supported by the side wall 35 or the boundary wall 32 of the main body part 21 and maintain a spiral shape. At this time, the drug volatilization body 10 wound in a spiral shape may be supported only by the side wall 35 of the main body 21. The drug volatilization body 10 wound in a spiral shape acts to return to a flat state before the drug volatilization body 10 is wound. Due to this force, an appropriate gap is formed between each of the plurality of layers, and further expansion is prevented by the side wall 35 of the main body 21, and the spiral shape is maintained while being supported by the side wall 35.

  FIG. 4A is a diagram illustrating an example of the drug volatilization body 10 according to the first embodiment of the present invention. The chemical volatilization body 10 has a strip shape and is formed of a material capable of holding or absorbing a liquid volatile chemical. The chemical volatilization body 10 may be a knitted fabric, a woven fabric, a cloth, a nonwoven fabric, absorbent cotton, gauze, paper, cardboard, a net, or a film formed by knitting fibers.

  The size of the drug volatilization body 10 is preferably about 10 mm in length, about 400 to 500 mm in width, and about 1 mm in thickness, but is not limited thereto, and can be accommodated in the drug volatilization container 20 by winding in a spiral shape. Any size that can be accommodated in the portion 34 may be used. The size of the spiral shape is preferably about 35 mm for the radius of the outer circle and about 25 mm for the inner circle, but is not limited to this, and is determined when it is housed in the container 34 of the drug volatilization container 20. Any length may be used.

  FIG. 4B is a diagram illustrating a preferred example of the chemical volatilization body 10 according to the first embodiment of the present invention. In the example of FIG. 4B, the chemical volatilization body 10 is a knitted fabric formed by knitting fibers, and is knitted so as to have a plurality of openings 11. By using a knitted fabric as shown in FIG. 4B, the surface of the chemical volatilization body 10 can be made uneven by the stitches, the surface area can be increased, and the volatile chemical can be more easily volatilized.

The chemical volatilization body 10 may be formed of a material other than the knitted fabric as shown in FIG. 4B, but preferably has a plurality of openings 11. The plurality of openings 11 may be of a size that allows ventilation. The total area of the drug volatilization body 10 is preferably about 44 cm ² , but is not limited thereto, and it is sufficient that a sufficient volatilization amount can be secured. For example, the total area of the drug volatilization body 10 is about 20 to 100 cm. ^It may be ² . Moreover, the weight of the chemical volatilization body 10 is preferably about 50 to 500 g per 1 m ² , more preferably about 100 to 300 g per 1 m ² .

  FIG. 5A is a plan view of the chemical volatilization device according to the first embodiment of the present invention. The medicine filling part 30 of the medicine volatilization container 20 is visible through the medicine filling port 31 of the lid part 22, and at least the surface of the center part of the medicine filling part 30 is exposed so as to be directly in contact with the outside air. Moreover, the chemical volatilization body 10 is also visible through the vent hole 33 of the lid part 22, has good air permeability, and volatilizable chemicals are easily volatilized. In addition, the number and arrangement | positioning of the some ventilation hole 33 shown to FIG. 5A are examples, and are not restricted to this.

  5B is a cross-sectional view taken along line VB-VB of the chemical volatilization apparatus in FIG. 5A. As shown in FIG. 5B, the medicine filling portion 30 has a raised shape. In the example of FIG. 5B, the medicine filling unit 30 has a shape that is raised in a substantially conical shape in a substantially vertical direction, but is not limited thereto, and is, for example, a polygonal pyramid shape such as a hemispherical shape, a triangular pyramid, or a quadrangular pyramid. It may be.

  5B is preferably about 10 °, but is not limited thereto, and may be a desired angle such as about 5 ° to 20 °. The height h of the bulge of the medicine filling portion 30 in FIG. 5B, that is, how much the apex p of the medicine filling portion 30 bulges in the vertical direction with reference to the boundary b between the medicine filling portion 30 and the accommodating portion 34. The height h shown is preferably about 2 mm, but is not limited thereto, and may be any height such as about 1 mm to 7 mm.

<Volatilization test>
In the first embodiment, the chemical volatilization body 10 has a band shape and is wound in a spiral shape. By winding in a spiral shape, the chemical volatilization container 20 and the chemical volatilization device 1 can be miniaturized, but in this case, it is verified whether the volatilization amount is not reduced as compared with the case where the chemical volatilization is not performed. The test for was done.

1. As a test sample A, a net-shaped drug volatilizer having a strip shape similar to the drug volatilizer 10 according to the first embodiment of the present invention and having a plurality of openings similar to the plurality of openings 11 in FIG. 4B is used. Prepared. The total area of the test specimen A is 44 cm ² , and the exposed area of the test specimen A is 11 cm ² . Here, the exposed area refers to the area of the portion where the drug volatilization body is exposed to the outside air without being covered by the drug volatilization container. The test specimen A is spirally wound like the drug volatilization body 10 according to the first embodiment of the present invention, and is a cylindrical drug volatilization container similar to the drug volatilization container 20 according to the first embodiment of the present invention. Stored.

As test specimens B for comparison with the test specimens A, the same total area 44cm 2 and the test sample ^A, was prepared planar chemical volatilization of exposed area 11cm ^2. The test specimen B has a net shape having a plurality of openings similar to the plurality of openings 11 in FIG. The test sample B was stored in a square container while maintaining a flat shape.

  Test sample A and test sample B were impregnated with 600 mg of lavender oil.

2. As a specimen volatilization place for conducting the specimen volatilization place volatilization test, a transpiration chamber was prepared in which the temperature was set to 27 ± 2 ° C. and the humidity was set to 60 to 80% RH. Test specimen A and test specimen B stored in each container were placed in the transpiration chamber, and changes in volatilization amount for 8 days from the start of volatilization were observed.

3. Test Results FIG. 6 is a diagram showing the results of the volatilization test of the chemical volatilization body. As shown in the graph of FIG. 6, there was almost no difference between the test sample A and the test sample B over 8 days from the start of volatilization, and the volatilization amount was almost the same. That is, even when the test specimen A is wound in a spiral shape, or even when the test specimen B is kept flat without being spirally wound, the same volatilization amount, It was confirmed that the duration could be secured.

  Thus, the volatilization amount sufficient while enabling it to accommodate in a smaller container by winding the chemical volatilization body 10 by 1st Example of this invention in the shape of a spiral, and accommodating in the chemical volatilization container 20. Can be secured.

  In the first embodiment, an example of a columnar drug volatilization apparatus 1 as shown in FIG. 1 and the like is shown, but the present invention is not limited to this, and the drug volatilization apparatus 1 may be a polygonal column shape such as a triangular prism or a quadrangular column. Good. For example, when the medicine volatilization apparatus 1 is formed in a polygonal column shape, the shape of the accommodating portion 34 of the medicine volatilization container 20 may also be a hollow polygon shape. Moreover, when the medicine volatilization apparatus 1 is made into a polygonal column shape, the shape of the medicine filling portion 30 may be made polygonal along with it, or may be a circular shape as shown in FIG. Moreover, when the medicine volatilization apparatus 1 is formed in a polygonal column shape, the shape of the medicine filling port 31 may be polygonal, or may be a circular shape as shown in FIG. Further, when the drug volatilization device 1 has a polygonal column shape, the plurality of boundary walls 32 may be arranged at intervals along the outer periphery of the drug filling unit 30. It may be arranged so as to be spaced along the outer periphery of the polygonal shape, or arranged in a circular shape with a space between each other at the boundary between the medicine filling portion 30 and the accommodating portion 34 as in FIG. You may do it.

  Further, for example, when the drug volatilization apparatus 1 has a polygonal column shape, if the shape of the container 34 of the drug volatilization container 20 is a hollow polygonal shape, the drug volatilization body 10 also has a circular spiral shape as shown in FIG. Instead of being wound around, it may be wound into a polygonal spiral according to the shape of the accommodating portion 34. At that time, the chemical volatilization body 10 may be supported only by the side wall 35 of the main body 21 of the chemical volatilization container 20 or may be supported by both the side wall 35 and the boundary wall 32.

  Further, the chemical volatilization device 1 may be used by being attached to a wrist belt such as a wristwatch belt or a waist strap when used. In order to allow the chemical volatilization apparatus 1 to be attached to a wrist belt, a waist strap, or the like, an insertion hole or an attachment / detachment mechanism for passing the belt, the waist cord, or the like may be further provided in the main body portion 21 of the chemical volatilization container 20. Good. Moreover, the chemical volatilization apparatus 1 may be attached to a belonging such as a bag by a strap, a belt, or the like. In order to allow the chemical volatilization apparatus 1 to be attached to a belonging such as a bag by a strap or a belt, an insertion hole or an attachment / detachment mechanism for allowing the strap or belt to pass through is provided in the main body 21 of the chemical volatilization container 20. It may be.

As described above, the drug volatilization apparatus 1 according to the present invention has a shape in which the drug filling portion 30 provided in the drug volatilization container 20 is raised in a substantially conical shape in the substantially vertical direction, and thus has a shape raised in a substantially conical shape. The volatile chemical flows along the slope, and the volatile chemical can be efficiently impregnated in the chemical volatilization body 10. In addition, the raised drug filling part can effectively use the space in the drug volatilization container, which can contribute to reducing the size and weight of the entire drug volatilization container. The fear of adhering can also be avoided. Furthermore, when wound in a spiral shape, a plurality of layers of the chemical volatilization body 10 are generated, and gaps are generated between the plurality of layers, so that a sufficient volatilization amount can be secured. It is apparent that various changes can be made to these characteristic parts and the like without departing from the spirit of the present invention.
That is, although the above description has been made with reference to the embodiments, the present invention is not limited thereto, and it will be apparent to those skilled in the art that various changes and modifications can be made within the spirit of the present invention and the scope of the appended claims. .

DESCRIPTION OF SYMBOLS 1 Drug volatilization apparatus 10 Drug volatilization body 20 Drug volatilization container 21 Main body part 22 Lid part 30 Drug filling part 31 Drug filling port 32 Boundary wall 33 Vent hole 34 Storage part 35 Side wall 36 Vent hole

Claims (2)

A chemical volatilization container that contains a chemical volatilizer that holds a volatile chemical,
A main body for housing the chemical volatilization body;
A lid having a drug filling port in a substantially central portion;
The drug volatilization container characterized by having a raised drug filling part at a substantially central part of the main body part. A chemical volatilization device,
A chemical volatilizer that holds a volatile chemical;
A chemical volatilization container containing the chemical volatilization body,
The drug volatilization body is formed in a strip shape, wound in a spiral shape and accommodated in the drug volatilization container,
The drug volatilization container is
A main body for housing the chemical volatilization body;
A lid having a drug filling port in a substantially central portion;
The drug volatilization apparatus characterized by having a raised drug filling part at a substantially central part of the main body part.